Tempus AI Q2 2024 Earnings Report $50.45 +2.81 (+5.90%) As of 04:00 PM Eastern Earnings HistoryForecast Tempus AI EPS ResultsActual EPS-$6.77Consensus EPS -$4.41Beat/MissMissed by -$2.36One Year Ago EPSN/ATempus AI Revenue ResultsActual Revenue$165.97 millionExpected Revenue$159.10 millionBeat/MissBeat by +$6.87 millionYoY Revenue GrowthN/ATempus AI Announcement DetailsQuarterQ2 2024Date8/6/2024TimeN/AConference Call ResourcesTEM Earnings History Tempus AI Earnings HeadlinesTempus AI up after launching olivia AI-enabled personal health concierge appJanuary 21 at 10:22 PM | markets.businessinsider.comTempus AI, Inc. (TEM): Revolutionizing Patient Care with AI-Driven Health Concierge App, OliviaJanuary 21 at 7:22 PM | insidermonkey.comDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.January 22, 2025 | Weiss Ratings (Ad)Here's Why This Medical AI Stock Soared 35% on TuesdayJanuary 21 at 6:35 PM | investopedia.comWhy Tempus AI is Blowing Up After Nancy Pelosi Reveals Position in the StockJanuary 21 at 5:20 PM | msn.comWhy Tempus Ai Stock Is Skyrocketing TodayJanuary 21 at 3:40 PM | fool.comSee More Tempus AI Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Tempus AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tempus AI and other key companies, straight to your email. Email Address About Tempus AITempus AI (NASDAQ:TEM) Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.View Tempus AI ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings CSX (1/23/2025)Intel (1/23/2025)Texas Instruments (1/23/2025)Elevance Health (1/23/2025)Freeport-McMoRan (1/23/2025)General Electric (1/23/2025)Union Pacific (1/23/2025)American Express (1/24/2025)HCA Healthcare (1/24/2025)NextEra Energy (1/24/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
